|
Market Closed -
Other stock markets
|
After hours 12:30:23 | |||
| 74.76 EUR | +0.36% |
|
74.43 | -0.44% |
| 08:01am | Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand | RE |
| 10:18pm | US FDA approves first mRNA flu shot from Moderna | RE |
| Market Cap | 89.26B 103B 83.58B 76.45B 144B 9,798B 146B 978B 384B 4,895B 386B 378B 16,293B | P/E 2026 * |
12.2x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 101B 116B 94.22B 86.19B 163B 11,045B 165B 1,102B 433B 5,519B 435B 426B 18,368B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.91x |
| Free-Float |
88.34% | Yield 2026 * |
5.69% | Yield 2027 * | 6.04% |
Last Transcript: Sanofi
| 1 day | -0.11% | ||
| 1 week | +2.79% | ||
| Current month | +0.81% | ||
| 1 month | +0.09% | ||
| 3 months | -0.04% | ||
| 6 months | -6.88% | ||
| Current year | -9.97% |
| 1 week | 73.76 |  | 75.77 |
| 1 month | 72.23 | | 80.11 |
| Current year | 71.25 | | 84.99 |
| 1 year | 71.25 | | 90.75 |
| 3 years | 71.25 | | 110.82 |
| 5 years | 71.25 | | 110.82 |
| 10 years | 62.88 | | 110.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.36% | +2.79% | - | - | 103B | |
| +0.43% | +1.77% | +57.48% | +158.85% | 1,043B | |
| -0.31% | +0.13% | +50.16% | +47.99% | 621B | |
| -0.91% | -5.26% | +24.24% | +62.23% | 435B | |
| 0.00% | +3.20% | +46.70% | +37.70% | 361B | |
| +0.58% | -1.26% | +35.52% | +39.32% | 293B | |
| -1.55% | -6.84% | +7.20% | +8.86% | 251B | |
| -1.05% | +3.92% | +41.51% | +59.26% | 220B | |
| -0.24% | -11.27% | +1.42% | -46.20% | 201B | |
| -1.28% | -1.01% | +17.84% | +61.09% | 164B | |
| Average | -0.40% | -3.81% | +31.34% | +47.68% | 398.79B | |
| Weighted average by Cap. | -0.19% | -3.79% | +39.86% | +73.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.5B 54.74B 44.48B 40.69B 76.81B 5,214B 77.82B 520B 204B 2,605B 206B 201B 8,671B | 50.62B 58.34B 47.4B 43.36B 81.86B 5,557B 82.93B 555B 218B 2,777B 219B 214B 9,241B |
| Net income | 7.69B 8.86B 7.2B 6.59B 12.44B 844B 12.6B 84.26B 33.07B 422B 33.28B 32.56B 1,404B | 9.35B 10.78B 8.76B 8.01B 15.12B 1,027B 15.32B 102B 40.21B 513B 40.47B 39.59B 1,707B |
| Net Debt | 11.37B 13.1B 10.64B 9.74B 18.38B 1,248B 18.62B 125B 48.87B 623B 49.18B 48.11B 2,075B | 7.68B 8.85B 7.19B 6.58B 12.41B 843B 12.57B 84.09B 33B 421B 33.21B 32.49B 1,401B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | €74.76 | +0.36% | 18,587 |
| 26-08-05 | €74.49 | +0.26% | 14,031 |
| 26-08-04 | €74.30 | -0.36% | 22,110 |
| 26-08-03 | €74.57 | +0.55% | 19,312 |
| 26-07-31 | €74.16 | +1.97% | 31,862 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNW Stock
Select your edition
All financial news and data tailored to specific country editions
